Skip to main content
. 2015 May 15;4(5):e001775. doi: 10.1161/JAHA.115.001775

Table 2.

Survival for Entire Study Cohort and Stratified by Quintile of Mean Minutes/Day Active in the First 30 to 60 Days After Implantable Cardioverter-Defibrillator Implantation

Survival Outcomes Mean Baseline Activity (Minutes/Day) P Value*
Entire Study (N=98 437) 107.5±66.2 Quintile 1 (N=19 693) 32.5±13.5 Quintile 2 (N=19 691) 67.6±8.6 Quintile 3 (N=19 674) 97.3±8.9 Quintile 4 (N=19 692) 132.5±12.0 Quintile 5 (N=19 687) 207.7±58.5
Survival at 1 year (95% CI) 0.950 (0.948 to 0.951) 0.865 (0.860 to 0.870) 0.945 (0.942 to 0.948) 0.968 (0.965 to 0.970) 0.982 (0.980 to 0.984) 0.987 (0.986 to 0.989) <0.0001
Survival at 2 years (95% CI) 0.882 (0.879 to 0.884 0.713 (0.705 to 0.720) 0.858 (0.852 to 0.863) 0.916 (0.911 to 0.920) 0.947 (0.943 to 0.950) 0.965 (0.962 to 0.968) <0.0001
Survival at 3 years (95% CI) 0.818 (0.815 to 0.821) 0.593 (0.584 to 0.602) 0.774 (0.767 to 0.782) 0.855 (0.848 to 0.861) 0.906 (0.901 to 0.911) 0.939 (0.935 to 0.943) <0.0001
Survival at 4 years (95% CI) 0.761 (0.757 to 0.765) 0.500 (0.488 to 0.512) 0.704 (0.694 to 0.715) 0.794 (0.785 to 0.804) 0.865 (0.857 to 0.873) 0.908 (0.901 to 0.914) <0.0001

CI indicates confidence interval.

*

P value for trend across quintiles according to log-rank test.